Jaguar Health (JAGX) vs Medicus Pharma (MDCX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Medicus Pharma is the larger company by market cap ($3.2 million vs $3.0 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | JAGX | MDCX |
|---|---|---|
| Share price | $0.227 | $1.14 |
| Market cap | $3.03M | $3.16M |
| 1-day change | -30.58% | -2.16% |
| YTD return | — | -25.82% |
| 1-year return | — | -46.71% |
| EPS (TTM) | $-257.15 | $-76.65 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $11.51M | — |
| Revenue growth (YoY) | -1.52% | — |
| Net income (latest FY) | $-53.58M | $-47.28M |
| Gross margin | 67.21% | — |
| Operating margin | -398.82% | — |
| Net margin | -465.42% | — |
| 52-week high | $981.75 | $114.00 |
| 52-week low | $0.22 | $1.06 |
| Distance from 52-week high | -99.98% | -99.00% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +296.48% |
| Average volume | 2.40M | 116.55K |
| Shares outstanding | 13.35M | 2.79M |
| Employees | 47 | 16 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Jaguar Health
JAGX stock →Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. It operates through two segments, Animal Health and Human Health.
Health Care · Biotechnology: Pharmaceutical Preparations · 47 employees
About Medicus Pharma
MDCX stock →Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin.
Health Care · Biotechnology: Pharmaceutical Preparations · 16 employees
JAGX vs MDCX FAQ
Which is bigger, Jaguar Health or Medicus Pharma?
Medicus Pharma (MDCX) is larger, with a market capitalization of $3.16M compared with $3.03M for Jaguar Health (JAGX).
Are Jaguar Health and Medicus Pharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.